Morphoceuticals Inc

bioelectrome, multi-omics, AI

repairingsmall molecule

morphoceuticals.com·Boston, Massachusetts, United States·$8M total funding

01Overview 02People 03Projects 04Concepts 05Patents 06Public records 07Belief evolution

Plate C · C-9NYQ

Projects

Bioelectrome atlas platform

exploratory

platform · high · Wed Feb 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Build an atlas of bioelectric patterns to identify ways to switch on dormant systems controlling tissue repair, organ regeneration, and disease treatment.

Multi-omics, bioelectric profiling, and AI-driven analysis of the bioelectrome to guide manipulation of bioelectric patterns.

Company reported an $8 million Seed-2 round to advance its electroceutical approach to regenerative medicine.

Adult frog limb regeneration drug-combination program

preclinical

research program · high · Thu Jan 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Induce regeneration of functioning limbs, tissues, and organs, with potential future application to loss of organs and limbs.

Novel drug combination evaluated in adult frogs in a long-term regeneration study by Morphoceuticals founders.

Morphoceuticals hailed publication of successful adult frog limb-regeneration results in Science Advances.

The supplied BioSpace record states the study showed successful regeneration in adult frogs using a novel drug combination.

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence